Objectives To systematically review reasons for the willingness to participate in biomedical
human subjects research in low‐and middle‐income countries (LMICs). Methods Five …

HIV vaccine preparedness studies (VPS) are important precursors to HIV vaccine trials. As
well, they contribute to an understanding of motivators and barriers for participation in …

Develo** and disseminating a preventive HIV vaccine is a primary scientific and public
health objective. However, little is known about HIV vaccine acceptability in the high …

Background Dengue virus infection is the most rapidly spreading vector-borne disease in
the world. Essential research on dengue virus transmission and its prevention requires …

Background. HIV/AIDS remains a leading cause of death in adolescents (aged 15-25 years),
and in sub-Saharan Africa HIV-related deaths continue to rise in this age group despite a …

The purpose of this study was to explore local perceptions and experiences regarding
vaccines in general and HIV vaccines and vaccine trials in the Dominican Republic. In-depth …

Persistently high rates of HIV infection in sub-Saharan Africa have driven the exploration for
additional methods of prevention, such as microbicides. Multi-site, field-based clinical trials …

Though engaging communities in research processes has several advantages and
implications, research efforts are poorly embedded in and linked with communities …

Objectives: Adolescents may be appropriate for inclusion in biomedical HIV prevention trials.
Adolescents' overall willingness to participate (WTP) in biomedical HIV prevention trials was …

In anticipation of a future HIV vaccine, we mapped the different personal positions regarding
HIV vaccination of people in Togo. In early 2014, 363 adults indicated their willingness to …